Trials / Unknown
UnknownNCT05370625
To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
A Multicentric, Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Valbiotis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The main objective of the study will be to compare the efficacy of a 2.65 g/day dose of TOTUM-854 versus placebo in decreasing SBP in subjects with high-normal blood pressure and Grade I hypertension following 12 weeks of daily intake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Totum-854 | To compare Totum-854 with Placebo on blood pressure |
| DIETARY_SUPPLEMENT | Placebo | Five capsules per day to consume orally in two intakes |
Timeline
- Start date
- 2022-05-30
- Primary completion
- 2023-12-01
- Completion
- 2024-04-01
- First posted
- 2022-05-11
- Last updated
- 2023-07-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05370625. Inclusion in this directory is not an endorsement.